DFDA

Alcohol Abstinence

Treatment for Alcoholic Cardiomyopathy

Typical Dosage: complete cessation

Effectiveness
95%
Safety Score
100%
Clinical Trials
0
Participants
10K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
100
DangerousModerateSafe
Treatment Details
Dosage Range
complete cessation
Time to Effect
3-6 months
Treatment Duration
lifetime
Evidence Quality
HIGH
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$500
Side Effect Mgmt:$2,000
Total Annual:$2,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
QALYs Gained
2
Outcome-Based Costs
Cost per Responder
$4,167
Cost per Remission
$10,000
Alcohol Abstinence Outcomes

for Alcoholic Cardiomyopathy

Efficacy Outcomes
Overall Effectiveness
+95%
Response Rate
+60%
Remission Rate
+25%
Common Side Effects
Alcohol withdrawal syndrome
+50%
Delirium tremens
+5%

Sources:

oatext.com
oatext.com
escardio.org

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov